SCHEDULE 13G/A: Vanguard Group Discloses 4.41% Passive Stake in Elevation Oncology Inc.

The Vanguard Group has filed a Schedule 13G, reporting a passive beneficial ownership of 4.41% in Elevation Oncology Inc. as of December 31, 2024.

Summary

• The Vanguard Group reported beneficial ownership of 2,610,045 shares of Elevation Oncology Inc. common stock.
• This ownership represents 4.41% of the total class of securities.
• The filing is a Schedule 13G, indicating that the shares are held for passive investment purposes and not with the intent to influence control of the issuer.
• The Vanguard Group holds sole dispositive power over 2,537,127 shares and shared dispositive power over 72,918 shares.
• The Vanguard Group holds sole voting power over 0 shares and shared voting power over 60,449 shares.

Sentiment

Score: 5

Explanation: The document is a routine Schedule 13G filing disclosing a passive ownership stake, which is neither inherently positive nor negative for the issuer's operational performance or strategic direction.

Positives

• A significant institutional investor, The Vanguard Group, maintains a stake in Elevation Oncology Inc., indicating continued institutional interest in the company.

Negatives

• The Vanguard Group's beneficial ownership is below the 5% threshold, classifying it as a passive investment and not indicating an activist stance or significant new strategic involvement.

Future Outlook

NA

Management Comments

• The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a routine disclosure of beneficial ownership by a large institutional asset manager, The Vanguard Group, in a publicly traded company, Elevation Oncology Inc. It reflects a passive investment strategy typical of such funds, rather than an active or strategic industry move.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake.

Key Dates

Keywords

Elevation Oncology Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing